Found: 18
Select item for more details and to access through your institution.
Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 1, p. 1, doi. 10.1007/s00280-006-0237-2
- By:
- Publication type:
- Article
A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 1, p. 9, doi. 10.1007/s00280-006-0239-0
- By:
- Publication type:
- Article
Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 1, p. 17, doi. 10.1007/s00280-006-0253-2
- By:
- Publication type:
- Article
Thalidomide and celecoxib as potential modulators of irinotecan's activity in cancer patients.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Early intervention with epoetin beta prevents severe anaemia in patients with solid tumours receiving platinum-based chemotherapy: results of the NeoPrevent study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 1, p. 35, doi. 10.1007/s00280-006-0251-4
- By:
- Publication type:
- Article
A pharmacokinetic and safety study of a novel polymeric paclitaxel formulation for oral application.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 1, p. 43, doi. 10.1007/s00280-006-0245-2
- By:
- Publication type:
- Article
A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Novel tetrahydroisoquinolin-ethyl-phenylamine based multidrug resistance inhibitors with broad-spectrum modulating properties.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 1, p. 71, doi. 10.1007/s00280-006-0248-z
- By:
- Publication type:
- Article
A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 1, p. 79, doi. 10.1007/s00280-006-0240-7
- By:
- Publication type:
- Article
Fatality involving vinblastine overdose as a result of a complex medical error.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 1, p. 89, doi. 10.1007/s00280-006-0246-1
- By:
- Publication type:
- Article
Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 1, p. 105, doi. 10.1007/s00280-006-0252-3
- By:
- Publication type:
- Article
Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 1, p. 113, doi. 10.1007/s00280-006-0250-5
- By:
- Publication type:
- Article
RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 1, p. 127, doi. 10.1007/s00280-006-0233-6
- By:
- Publication type:
- Article
RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide.
- Published in:
- 2007
- By:
- Publication type:
- Correction notice
A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 1, p. 139, doi. 10.1007/s00280-006-0267-9
- By:
- Publication type:
- Article
Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma.
- Published in:
- 2007
- By:
- Publication type:
- Letter